Skip to content
value.today

Health Outcomes Sciences, Inc.

🇺🇸 Overland Park, Kansas, USATelecommunicationsFounded 2014
Total raised
$15 M
2 rounds on record
Latest round
$2 M
Jun 2017
First round on record
Mar 2014
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Health Outcomes Sciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2017$2 MNo. 2Under $2 million

Health Outcomes Sciences, Inc.: Raise no. 2, Jun 2017

Investors in this round

12 investors had bought by the notice of Jun 29, 2017: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
$1,413
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Spertus · Executive Officer, Director
  • Matt Halle · Executive Officer
  • Brian Burns · Director
  • John Spertus · Director
  • Ralph Brindis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matt Halle, President. Source: SEC Form D, newest notice filed Jun 29, 2017. Read the notice at the SEC.

equitySEC
Mar 2014$13 MNo. 1$10 to $50 million

Health Outcomes Sciences, Inc.: Raise no. 1, Mar 2014

Investors in this round

20 investors had bought by the notice of Mar 12, 2014: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
$9,017
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jim Stickley · Executive Officer · Chief Technology Officer
  • John Spertus · Executive Officer, Director · Chief Medical Officer
  • Matthew Wilson · Executive Officer, Director · President and Chief Executive Officer
  • Michael Fiorito · Executive Officer · Vice President, Chief Operating Officer, Treasurer and Secretary
  • Brian Burns · Director
  • Charles McKay · Director
  • Keith Harrington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew J. Wilson, President and CEO. Source: SEC Form D, newest notice filed Mar 12, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Health Outcomes Sciences, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2017).

    SEC Form D · Jun 2017

  • The industry group it chose in its notices: Telecommunications.

    SEC Form D · Jun 2017

That is all the official record says: Health Outcomes Sciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Health Outcomes Sciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Health Outcomes Sciences, Inc.
NameRoleNamed in
James SpertusExecutive officerJun 2017
Matt HalleExecutive officerJun 2017
Jim StickleyChief Technology OfficerMar 2014
John SpertusChief Medical OfficerMar 2014
Matthew WilsonPresident and Chief Executive OfficerMar 2014
Michael FioritoVice President, Chief Operating Officer, Treasurer and SecretaryMar 2014
Brian BurnsDirectorJun 2017
James SpertusDirectorJun 2017
John SpertusDirectorJun 2017
Ralph BrindisDirectorJun 2017
Charles McKayDirectorMar 2014
Keith HarringtonDirectorMar 2014
Matthew WilsonPresident and Chief Executive OfficerMar 2014